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Edited by Frances ShannonAbstract HIV Tat has been known to have multiple regulatory
roles including replication of HIV and modulation of cellular ki-
nases. We investigated whether signaling kinase PKR plays a
critical role in mediating Tat-induced cytokine dysregulation.
We showed Tat induction of IL-10 dysregulation is associated
with PKR activation. To examine the mechanism involved, inhi-
bition of PKR activity abrogated the Tat-induced cytokine
induction. We next identiﬁed that the MAP kinases including
ERK-1/2 and p38 are downstream of PKR in these Tat-induced
pathways. Thus, PKR may play a critical role in mediating the
subversive eﬀects of HIV Tat resulting in IL-10 induction.
 2005 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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The genome of HIV encodes a number of essential structural
proteins as well as regulatory proteins to enhance its replica-
tion and survival in the host. Tat, one of the regulatory pro-
teins, acts as a potent transcriptional activator by binding to
the transactivation response (TAR) element of the HIV long
terminal repeat (LTR) to mediate viral gene expression [1].
Additionally, HIV utilizes Tat to perturb intracellular func-
tions and evade immune responses of the host. To achieve this,
it has been shown that Tat is secreted from infected cells for
subsequent uptake by other cells to exert its biological eﬀects
including cytokine expression [2]. Tat also induces the expres-
sion of speciﬁc chemokine receptors such as CCR5 and
CXCR4, which are important for HIV infection [3].
Following virus infection, the intercellular coordination of
host response is regulated, at least in part, by interferon
(IFN) and proinﬂammatory cytokines. Binding of IFN to its
cognate receptor induces PKR, a double-stranded RNA-acti-Abbreviations: 2-AP, 2-aminopurine; ERK-1/2, p44 and p42 MAP
kinases; IL, interleukin; MAP, mitogen-activated protein; PBM,
human primary blood monocytes; RT, reverse transcription; TNF,
tumor necrosis factor
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pha subunit of eukaryotic initiation factor 2 (eIF2a), leading
to inhibition of translation [4]. Additionally, other stress
inducers including LPS can induce PKR by activation of cell
surface or transmembrane receptors including CD14 or Toll-
like receptors [5]. This leads to induction of cytokines includ-
ing interleukin (IL)-6, IL-10 and tumor necrosis factor
(TNF)-a to ﬁght the invading pathogen. Other biological func-
tions of PKR including its role in mediating TNF-a- or virus-
induced apoptosis have been previously reported [6,7]. Among
these, we have shown tumor suppressor gene p53 acts down-
stream of PKR in TNF-regulated apoptosis.
Several reports have indicated PKR plays an important role
in resistance to HIV infection due to its role in mediating IFNs
eﬀects on the inhibition of HIV-1 translation [8,9]. Moreover,
the regulation of HIV-LTR transactivation is mediated by
PKR through the transcription factor NF-jB [10]. NF-jB is
known to regulate the expression of cytokines including IL-
6, IL-8 and TNF-a. Similarly, the expression of these proin-
ﬂammatory cytokines is regulated by nuclear factor NF-IL6,
implicating its potential role in HIV pathogenesis.
In light of the critical role of PKR in immune defense, we
examined the signaling pathways involved in HIV Tat inter-
actions with PKR, and its consequent eﬀects in the activa-
tion of transcription factors and induction of cytokines.
We further delineated that the cytokine induction is medi-
ated by mitogen-activated protein (MAP) kinases including
p38 and p44 and p42 MAP kinases (ERK-1/2), which
act as downstream eﬀectors of PKR in cellular signaling
transduction.2. Materials and methods
2.1. Cell culture and primary blood monocyte isolation
Primary blood monocytes (PBM) were isolated from buﬀy coats of
healthy blood donors (Source: Hong Kong Red Cross Blood Transfu-
sion Service) by Ficoll-Paque (Amersham Pharmacia Biotech.) density
gradient centrifugation. PBM were resuspended in RPMI 1640 med-
ium supplemented with 5% autologous plasma and cultured for 1 h.
Following removal of non-adherent cells, adherent cells have been
shown to be >90% positive using anti-CD14 antibodies staining by
ﬂow cytometer. Additionally, we used derivatives of U937 promonocy-
tic cells (U9K-M) that are deﬁcient in PKR activity to conﬁrm the role
of PKR in the Tat-induced cytokine expression[11]. The activity of
PKR in U9K-M (results not shown) was conﬁrmed by diﬀerent exper-
iments including phosphorylation of eIF2a and PKR-mediated apop-
tosis assays as previously reported [6].blished by Elsevier B.V. All rights reserved.
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The recombinant HIV Tat protein was produced by using GST-Tat
1 86R plasmid (NIH AIDS Research and Reference Reagent
Program). Cleaving GST-Tat protein with thrombin produced the re-
combinant Tat protein. The mock control was prepared by using
pGEX-2T plasmid without Tat cDNA insert. The purity and the quan-
tity of the fusion protein were examined by sodium dodecyl sulfate–
polyacrylamide gel electrophoresis (SDS–PAGE) and Coomassie blue
staining. The levels of endotoxin were measured by Pyrotell assay kit
(Associates of Cape Cod) and were shown to be less than 0.5 EU/ml
in these samples. The biological activity of the Tat protein was con-
ﬁrmed by HIV-LTR luciferase activity (results not shown).
2.3. RNA extraction and RT-PCR
Total cellular RNA was extracted by TRIzol and reverse transcribed
into cDNA by SuperScript II system (Invitrogen). The reverse trans-
criptase (RT)-PCR primer sets for cytokines and GAPDH were as
follows. IL-6 (upstream:5 0-ATGAACTCCTTCTCCACAAGCGC-3 0;
downstream:50-GAAGAGCCCTCAGGCTGGACTG-3 0), IL-10 (up-
stream: 5 0-ATGCCCCAAGCTGAGAACCAAG-3 0; downstream:
5 0-TCTCAAGGGGCTGGGTCAGCTA-3 0), TNF-a (upstream: 5 0-
GGCTCCAGGCGGTGCT TGTCC-3 0; downstream: 5 0-AGAC-
GGCGATGCGGCTGATG-3 0), and GAPDH (upstream: 5 0-AC-
CACAGTCCATGCCATCAC-3 0; downstream: 5 0-TCCACCAC-
CCTGTTGCTGTA-3 0). The thermal cycling condition for
primer annealing was at 60 C, followed by 25–35 cycles of ampliﬁca-
tion depended on the diﬀerent genes.
2.4. Real-time RT-PCR
Real-time PCR was performed by using SYBR Green PCR Master
Mix (Applied Biosystems). The reactions were cycled 40 times under
the following parameters: 95 C for 30 s, 56 C for 30 s, 72 C for
30 s. The mRNA level of Tat-induced cytokines was normalized to
that of b-actin and compared with the untreated control. Samples were
prepared from at least 3 separate experiments. All the reagents used for
TaqMan Real time RT-PCR were purchased from Applied Biosys-
tems. Two hundred nanograms of RNA were reverse transcribed using
GeneAmp RNA PCR kit to synthesize cDNA. The IL-6, IL-10 and
TNF-a TaqMan probes were purchased from the Applied Biosystems
and 18S RNA was used as an internal control.
2.5. ELISA
The culture supernatants of Tat- and other kinase inhibitors-treated
PBM were collected at diﬀerent time intervals and stored at 70 C.
The level of TNF-a was measured by a TNF-a speciﬁc ELISA kits
(R&D system).
2.6. Role of PKR and MAP kinases in signal transduction
The PBM were incubated with inhibitors for individual kinases
including 2-aminopurine (2-AP) (Sigma–Aldrich) for PKR, PD98059
for ERK-1/2 kinase, or SB203580 for p38 MAP kinase (Calbiochem),
respectively, for 1 h prior to Tat protein treatment. Protein and RNA
were extracted from the treated cells at diﬀerent time points for further
analysis.
2.7. Electrophoretic mobility shift assay (EMSA)
The DNA-protein binding reaction was performed by incubating
2 lg of nuclear extracts of Tat-treated cells with 12 fmole of 32P-
labeled double-stranded NF-IL6 oligdeoxyonucleotide probe (wild-
type: 5 0-GATCGGACGTCACATTGCACAATCTTAATAAT-3 0;
mutant: 5 0-GGACGTCACACTACAAACTCTTAATAA-3), 1· bind-
ing buﬀer (25 mM HEPES pH 7.9, 0.5 mM EDTA, 0.5 mM DTT, 1%
NP-40, 12% glycerol, and 50 mM NaCl), and 0.5 lg of poly (dI:dC) at
room temperature for 30 min. The reaction product was resolved in 5%
non-denaturing PAGE in Tris–glycine buﬀer, dried and detected by
autoradiography.
2.8. Western blot analysis
The procedure for collection of protein extracts has been described
previously [12]. Thirty micrograms of cytoplasmic proteins or two
micrograms of nuclear proteins were separated by SDS–PAGE and
transferred to nitrocellulose membrane for probing overnight with pri-
mary antibodies. The antibodies against eIF2a, phosphorylated eIF2a,p38 MAP kinase, phosphorylated p38 MAP kinase, ERK-1/2 and
phosphorylated ERK-1/2 were purchased from Cell Signaling Technol-
ogy. The anti-PKR, anti-C/EBP-b, anti-p65 (Rel A), anti-actin and
anti-IjB-a antibodies were purchased from Santa Cruz Biotechnology.
The antibody against phosphorylated PKR was purchased from
Biosource International. Following washings, the membranes were
incubated with the corresponding secondary antibodies conjugated
with horseradish peroxidase (BD Transduction Lab). The signal was
visualized by enhanced chemiluminescence kit (Amersham Pharmacia
Biotech.).
2.9. Statistical analysis
Statistical analysis of the comparison between groups is calculated
by using Students t test. Data were presented as the mean ± standard
deviation (S.D.). Values of P < 0.05 were considered signiﬁcant.3. Results
3.1. Tat induces the expression of cytokines in a dose- and
time-dependent manner
To examine the signaling pathways of Tat-induced intracel-
lular events, we initially demonstrated that Tat induces the
expression of cytokines in PBM. Real-time RT-PCR results
showed that Tat induced the transcription of IL-6, IL-10 and
TNF-a in a dose-dependent manner (Fig. 1A). When followed
over a period of 12 h, the induction of IL-6, IL-10 and TNF-a
mRNA in PBM treated with Tat (500 ng) peaked at 3 h (Fig.
1B and C, lane 3). For IL-6, the elevated mRNA level was
maintained up to 3 h and started to decline between 3 and
6 h after Tat treatment. In contrast, the mRNA levels of IL-
10 and TNF-a returned to the basal level at 6 h (Fig. 1B and
C, lane 4). We further demonstrated that the levels of TNF-
a protein started to increase at 3 h and peak at 10 h following
Tat treatment (Fig. 1D). Additionally, we have shown that
extracellular Tat protein, immobilized by coating on culture
wells, is capable of inducing cytokine expression in the PBM
(results not shown).
3.2. Inhibition of PKR results in abrogation of Tat-induced
cytokine expression
Since PKR regulates IFN induction in virus infections [7], we
investigated whether Tat-induced cellular eﬀects are dependent
on PKR activity. Following incubation with diﬀerent concen-
trations of 2-AP, a PKR inhibitor, for 1 h, PBM were treated
with Tat protein for another 3 h. The induction of IL-10 and
TNF-a were potently inhibited by 2 mM of 2-AP (Fig. 2A,
lanes 2 and 3). For IL-6, a higher concentration (5 mM) of 2-
AP was needed to inhibit the induction (Fig. 2A, lane 4). At
these concentrations of 2-AP (up to 10 mM), the cells did not
show any signs of cytotoxicity and remained viable in subse-
quent cell assays (results not shown)[13]. Another set of exper-
iments using PKR-deﬁcient U9K-M cells was performed to
conﬁrm the 2-AP eﬀects. After 6 h of Tat protein treatment,
the induction of IL-10 and TNF-a mRNA was observed in
the control U9K-C cells (transfected with the control plasmid
without PKR insert [11]) but not in the U9K-M cells (Fig.
2B, lanes 3 versus 6, P < 0.05). We next measured the TNF-a
production in PBM pre-treated with or without 2-AP for 1 h
before the addition of Tat protein for 10 h. As shown in Fig.
2C, the production of TNF-a by Tat was abrogated by 2-AP
treatment (lanes 3–5). In the presence of 2-AP, we have demon-
strated that there was inhibition of Tat-induced phosphoryla-
tion of the PKR protein (Fig. 2E).
Fig. 1. Dose eﬀects and kinetics of Tat-induced cytokine expression in primary blood monocytes (PBM). (A) Real time RT-PCR of IL-6, IL-10 and
TNF-a was performed on PBM treated with Tat for 3 h. The untreated cells and mock reagent described in Section 2 was used as a control (lanes 1
and 2). The results have been normalized with the measurement of 18S mRNA levels. The experiment shown is representative of three independent
experiments. (B) RT-PCR analysis of IL-6, TNF-a and GAPDH of PBM treated with Tat (500 ng). The results shown are representative of at least
three independent experiments. (C) The cDNA from (B) were used to perform real-time quantitative PCR for IL-10. The results (mean ± S.D.)
shown have been normalized with the measurement of b-actin mRNA levels, and they are representative of three experiments performed. (D) PBM
were incubated with 500 ng of Tat protein over a period of 24 h. The culture supernatants were assayed for TNF-a by ELISA assays (n = 3).
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As the above results showed that inhibition of PKR activi-
ties abrogated the Tat-induced cytokine expression, we next
examined whether Tat can regulate the kinase activity of
PKR. We measured the levels of phosphorylated PKR in
Tat-treated cells at diﬀerent time intervals by immunoblot as-
says. The activity of PKR increased gradually from 30 min to
2 h (Fig. 2D), indicating the activation of PKR.3.4. PKR mediates Tat-induced NF-IL6 activation but not
NF-jB
To determine whether PKR regulates Tat-induced activation
of transcription factors, we investigated the nuclear transloca-
tion of NF-jB and NF-IL6 by Western analysis. Our results
showed that Tat could induce the degradation of NF-jB inhib-
itor, IjB-a, (Fig. 3A, lane 3). This degradation persisted in the
Tat-treated cells that were pretreated with 2-AP suggesting
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clear translocation of the NF-jB subunit, p65/RelA protein,
was unaﬀected by the treatment of 2-AP (Fig. 3B, lanes 3
and 4).
Nuclear translocation of NF-IL6 was detected in Tat-treated
PBM (Fig. 3C, lane 3). Such translocation of NF-IL6 could be
abrogated by inhibiting PKR (Fig. 3C, lane 4). In addition, the
EMSA results showed that the Tat-induced NF-IL6 DNA-
binding activity was inhibited by 2-AP (Fig. 3D, lanes 3 and
4). We have performed densitometric analysis of the results ob-
tained in Fig. 3D. The diﬀerence between the 2-AP treatment
(Fig. 3D, lane 5) and untreated control (Fig. 3D, lane 1) was
insigniﬁcant. The slightly increased binding in the 2-AP-trea-
ted cells may be due to non-speciﬁc activities (results not
shown). The use of 32P-labeled double-stranded NF-IL6 mu-
tant oligo was to demonstrate the speciﬁcity of the NF-IL6Fig. 2. PKR mediates Tat-induced cytokine expression. (A) PBM were pre-
incubation with Tat protein for 3 h (lanes 2–4). PBM without treatment (lan
PKR-deﬁcient U9K-M cell. Total RNA extracted from U9K-C and U9K-M
analysis. The untreated PBM (lanes 1 and 4) and those treated with moc
(mean ± S.D.) have been normalized with the measurement of b-actin mR
compared with untreated/mock is indicated as follows: \, P < 0.05. (C) Eﬀec
treatment: lane 1, PBM without treatment; lane 2, PBM treated with mock r
plus 2-AP; and lane 6, 2-AP treatment alone. Mean values and standard dev
were treated with 500 ng of Tat protein from 0 to 2 h (lanes 2–5). Cytoplasm
immunoblotted using antibodies speciﬁc for phosphorylated PKR. The same
protein to show the equal loading of protein. (E) PBM were treated with 500 n
experiment shown is representative of three independent experiments perforoligo. The 32P-labeled mutant oligo consists of modiﬁed NF-
IL6 enhancer sequence and thus would not allow for binding
of the NF-IL6 protein. Consequently, the binding of wild-type
NF-IL6 was observed in lane 3, while there was no binding to
the 32P-labeled mutated NF-IL6 oligo in lane 7 (Fig. 3D).
These results illustrated that the correct enhancer binding sites
are critical to the binding in the EMSA for NF-IL6. Taken to-
gether, the results indicated that PKR mediates the activation
of NF-IL6 but not NF-jB following induction by Tat in
monocytic cells.
3.5. p38 and ERK-1/2 MAP kinases mediate Tat-induced
cytokine induction
Previous studies showed that MAP kinases play key roles in
cytokine induction mediated by PKR in cells treated with LPS
[14]. We investigated whether these kinases are also involved intreated with diﬀerent concentrations of 2-AP for 1 h and followed by
e 1) were used as controls. (B) Eﬀects of Tat on cytokine expression in
cells treated with Tat for 6 h were used to perform real-time PCR
k reagent (Mock, lanes 2 and 5) were used as controls. The results
NA levels (n = 3). The statistical signiﬁcance of the fold of induction
ts of PKR inhibition on TNF-a production in PBM after 10 h of Tat
eagent; lane 3, PBM treated with Tat; lanes 4 and 5, PBM treated Tat
iation of the mean from triplicate experiments are as shown. (D) PBM
ic protein (30 g) was transferred to nitrocellulose membrane and then
membrane was stripped and incubated with antibodies speciﬁc for PKR
g Tat protein (lanes 3 and 4) with or without the presence of 2-AP. The
med on PBM obtained from diﬀerent donors.
Fig. 3. Eﬀects of 2-AP on Tat-mediated activation of NF-IL6 and NF-
jB. (A) Cytoplasmic proteins (30 lg) of PBM treated with Tat for 1 h
in the absence or presence of 5 mM 2-AP (lanes 3 and 4) were assayed
for IjB-a. The same membrane was stripped and incubated with anti-
actin antibodies to measure the total amounts of protein loaded. The
experiment shown is representative of three independent experiments.
Nuclear translocations of NF-jB (B) and NF-IL6 (C) in PBM were as
shown. Nuclear (2 lg, upper panel) and cytoplasmic (30 lg, lower
panel) proteins extracted from PBM that were treated with 500 ng of
Tat protein for 1 h with or without 2-AP treatment (lanes 3 and 4) were
analyzed by Western blot with antibodies against p65/Rel A protein
(B) or C/EBP-b (C). Cells without treatment (lane 1) or treated with
mock reagent (lane 2) were used as controls. (D) Eﬀects of 2-AP on
Tat-induced activation of NF-IL6 nuclear DNA binding activity.
EMSA was performed on nuclear proteins (2 lg) from PBM treated
with Tat protein (lane 3) or pre-treated with 2-AP followed by Tat
protein treatment for 1 h (lane 4). The 50· unlabelled oligos (lane 6)
and radiolabeled mutated NF-IL6 oligos (lane 7) were used as controls
to test for speciﬁcity of the binding. Cells without treatment (lane 1),
treated with mock reagents (lane 2), or 2-AP (lane 5) were used as
controls. Additionally, U937 cells treated with PMA for 48 h were used
as positive controls for NF-IL6 activation (lane 8). The experiment
shown is representative of three independent experiments from three
diﬀerent donors.
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sults showed that pretreatment with ERK-1/2 inhibitor
(PD98059, 1 lM) blocked the induced expression of IL-6and TNF-a mRNA by 83% (P < 0.05) and 52% (P < 0.05),
respectively (Fig. 4A, lane 6). For the p38 MAP kinase inhib-
itor (SB203580, 1 lM), it could inhibit both IL-6 and IL-10 by
90% (P < 0.05) and 66% (P < 0.05), respectively (Fig. 4A, lane
4). These results showed that the Tat-induced IL-6 mRNA
transcription is mediated by both p38 and ERK-1/2 MAP ki-
nases, whereas the expression of IL-10 and TNF-a is individu-
ally regulated by p38 and ERK-1/2 MAP kinases, respectively.
To examine the eﬀects of p38 and ERK-1/2 on TNF-a protein
levels, PBM were pre-treated with the respective inhibitors be-
fore Tat incubation. As shown in Fig. 4B, the production of
TNF-a was abrogated by SB203580 (62.6%, P < 0.05) or
PD98059 (74.6%, P < 0.05), thus conﬁrming the role of these
kinases in cytokine regulation by Tat.
3.6. p38 and ERK-1/2 MAP kinases act downstream of PKR in
Tat-induced PBM
We next investigated the relationship of p38 and ERK-1/2
MAP kinases with PKR in cytokine regulation. Since eIF2a
is an endogenous substrate of PKR, measuring the phosphor-
ylation status of eIF2a is indicative of PKR activity. As
shown, both inhibitors failed to inhibit the phosphorylation
of eIF2a (Fig. 4C, lanes 3–5; and lanes 3, 7 and 8). In other
words, both of the p38 and ERK-1/2 MAP kinases could
not regulate the activity of PKR. In order to conﬁrm that
PKR acts upstream of both MAP kinases, the Tat-induced
PBM were pre-treated with 2-AP. This resulted in reduced acti-
vation of p38 and ERK-1/2 MAP kinases as reﬂected by signif-
icant decreases in the phosphorylated form of the proteins
(Fig. 4D, lanes 2–4). Thus, the ﬁndings indicated that p38
and ERK-1/2 MAP kinases may act as downstream targets
of PKR in regulating cytokine induction by Tat.4. Discussion
Previous studies on the interaction of Tat and PKR have
yielded intriguing results. For instance, two reports demon-
strated the ability of Tat binding to PKR, resulting in inhibit-
ing its kinase activity in an in vitro model of protein–protein
interaction [15,16]. Furthermore, Tat can compete with PKR
for binding to eIF2a, a cellular substrate for kinase activity
of PKR [17]. These results suggest that Tat may act as an
inhibitor of PKR. Additionally, another report showed that
PKR mediates the activation of NF-jB by Tat [10]. In investi-
gating the mechanisms involved, our results revealed that Tat
induces the activity of PKR (Fig. 2D). These discrepancies in
results could be due to diﬀerent experimental settings. Most
of the previous studies have focused on the protein–protein
interaction of Tat and PKR in vitro using puriﬁed recombi-
nant proteins [15,16]. In our study, exogenous addition of
the recombinant Tat protein may interact with cell surface
receptors or was directly transported into the cell to trigger a
cascade of signal transduction.
Here, we demonstrated the relationship between exogenous
Tat and PKR in cytokine induction in human blood mono-
cytes. With the inhibition of PKR, the Tat-induced cytokine
expression was abrogated (Fig. 2). Thus, our results showed
that PKR may play a critical role in this intracellular signal
transduction process by Tat.
The host immune system utilizes multiple signaling path-
ways and diﬀerent transcription factors to mediate immune
Fig. 4. The role of p38 and ERK-1/2 MAP kinases in Tat-induced cytokine induction. (A) Eﬀects of inhibitors SB203580 (p38 kinase) and PD98059
(ERK1/2 MAP kinase) on Tat-induced expression of cytokine genes. Real-time PCR was performed on total RNA of PBM treated as follows: lane 1,
no treatment; lane 2, mock treatment; lane 3, Tat alone; lane 4, SB203580 pretreatment for 1 h and Tat for 3 h; lane 5, SB203580 pretreatment; lane 6,
PD98059 pretreatment and Tat for 3 h; lane 7, PD98059 treatment alone. (B) Eﬀects of MAP kinase inhibitors on Tat-induced production of TNF-a
protein. PBM were incubated with Tat protein for 10 h as follows: lane 1, no treatment; lane 2, mock treatment; lane 3, Tat treatment; lane 4, Tat and
SB203580 treatment; lane 5, SB203580 alone; lane 6, Tat and PD 98059 treatment; lane 7, PD98059 alone. Mean values and standard deviation of the
mean from triplicate experiments are shown. (C) Eﬀects of kinase inhibitors on Tat-induced phosphorylation of eIF2a. Anti-phosphorylated eIF2a
antibodies were used to performWestern blots on PBM treated as follows: lane 1, no treatment; lane 2, mock treatment; lane 3, Tat treatment; lanes 4
and 5, Tat and SB203580 treatment; lane 6, SB203580 alone; lanes 7 and 8, Tat and PD98059 treatment; and lane 9, PD98059 alone. The same
membrane was stripped and incubated with eIF2a antibodies to detect the total amounts of eIF2a. The experiment shown is representative of three
independent experiments. (D) Eﬀects of 2-AP on Tat-induced phosphorylation of p38 MAP and ERK-1/2 kinases. Cytoplasmic proteins (30 lg) were
extracted from PBM treated as follows: lane 1, no treatment; lane 2, Tat treatment; lanes 3 and 4, Tat with 2-AP treatment; lane 5, 2-AP alone. The
cytoplasmic proteins were immunoblotted with a panel of antibodies speciﬁc for phosphorylated-p38, p38, phosphorylated-ERK-1/2 or ERK-1/2 as
shown. The experiment shown is representative of three independent experiments.
3060 J.C.B. Li et al. / FEBS Letters 579 (2005) 3055–3062responses. For example, NF-jB has been shown to mediate
cytokine expression including IL-6, IL-10 and TNF-a [18–
20], and its activation is regulated by multiple kinase pathways
[21]. For further controls, transcription factors including C/
EBP, NF-AT and NF-IL6 are involved in cytokine expression
[22,23]. In light of critical roles of NF-B and NF-IL6, we inves-
tigated whether these factors play a role in the Tat-activated
and PKR-mediated pathways. Our results demonstrated that
Tat induced the degradation of IjB-a and subsequent nuclear
translocation of NF-jB subunit (Fig. 3A and B). The nuclear
translocation and binding activities of NF-IL6 were also en-
hanced by Tat treatment (Fig. 3C and D). The activities ofNF-IL6 but not NF-jB can be abrogated by the inhibition
of PKR with the use of 2-AP. Thus, we identiﬁed that Tat
can activate both NF-jB and NF-IL6 but the activation of
NF-jB is PKR-independent.
Transcription factor NF-IL6, which was initially identiﬁed
in IL-6 induction, is characterized by a basic DNA-binding do-
main linked to a basic leucine zipper dimerization motif. Sub-
sequent reports showed that IL-8, TNF-a, and CCR5 also
have the functional NF-IL6 binding sites in their respective
promoters [22,24,25]. NF-IL6 also has been shown to mediate
the transcriptional activation of HIV-1 LTR [26]. Interactions
of NF-IL6 with other transcription factors have resulted in
Fig. 4 (continued)
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that NF-IL6 serves a supportive role in multiple pathways for
mediating the eﬀects of extracellular inducers.
We also have identiﬁed downstream signaling kinase
pathways regulated by PKR that may mediate Tat-induced
cytokine expression. The key players examined were p38
and ERK-1/2 MAP kinases that are known to be critical
in regulating cytokine expression [27]. Our results showed
that ERK-1/2 and p38 MAP kinases have distinct roles in
Tat-induced and PKR-mediated cytokine production. Both
ERK-1/2 and p38 MAP kinases played a role in IL-6 tran-
scription (Fig. 4A, upper panel), whereas only p38 kinase
activity was involved in IL-10 regulation (Fig. 4B, middle
panel). The mechanism of PKR regulation of p38 kinase is
through the phosphorylation of MKK3/6, an upstream eﬀec-
tor of p38 kinase [14]. The Tat-induced TNF-a expression
can be regulated at both transcriptional and post-transcrip-
tional levels. For TNF-a transcription, ERK-1/2 plays a sig-
niﬁcant role in the Tat-induced cellular process (Fig. 4A,
lower panel). For TNF-a protein synthesis, both ERK-1/2
and p38 MAP kinases could play a role as reﬂected by
the use of the respective inhibitors (Fig. 4B). Taken to-
gether, these results suggest that the regulation of IL-10
and TNF-a mRNA synthesis are mediated by multiple path-
ways including the involvement of MAP kinases.
By its nature, cytokines have pleiotropic properties and their
regulated pathways have overlapping eﬀects in signal transduc-
tion. We showed that ERK-1/2 and p38 kinase are down-
stream eﬀectors of PKR, since inhibition of PKR abrogate
the phosphorylation of MAP kinases (Fig. 4D) but not vice
versa (Fig. 4C). The results in Fig. 4C showed that there were
increases in p-eIF2a levels when cells were treated with both
Tat and MAPK inhibitors, compared to either alone. In thiscase, it remains possible that MAPK may act upstream to in-
hibit PKR activity and reduced eIF2a levels. Taken together,
these ﬁndings suggest that Tat-induced PKR acts upstream
of MAP kinases in regulating its phosphorylation and activa-
tion. In previous ﬁnding, PKR-mediated activations of tran-
scription factors are via the activation of p38 MAP kinase
with LPS treatment [14]. Additionally, both the ERK-1/2
and p38 MAP kinases have been shown to regulate the activa-
tion of NF-IL6 [28]. Taken together, it appears that Tat-
induced and PKR-regulated cytokine induction is mediated
by p38 and ERK-1/2, leading to activation of transcription
factors.
Increased expression of cytokines in AIDS patients could be
due to the presence of opportunistic pathogens or due to direct
HIV infection of the immune cells [29,30]. It is also possible
that the elevated cytokine levels are due to Tat protein secreted
by the HIV-infected cells. In turn, Tat activates monocytes and
related immune cells through the activation of PKR and MAP
kinases to produce the cytokines. Consequently, these proin-
ﬂammatory cytokines activate NF-jB and NF-IL6 to further
enhance the replication of HIV via binding to their respective
enhancer sites in the HIV-LTR.
In summary, we have further delineated the mechanisms of
HIV Tat-induced PKR-mediated events in the host cell. The
consequences of such induction are most likely cell type spe-
ciﬁc. In response to the virus infection, immune cells activate
antiviral pathways including PKR and related IFN-stimulated
genes. In its counter-attack, HIV interacts with antiviral ki-
nases including PKR to activate the immune system and ex-
ploits nuclear factors including NF-IL6 and NF-jB to
enhance its own replication. Thus, HIV evades the immune
system by exploiting the antiviral proteins and cytokines to en-
hance its own life cycle.
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